parasit
toxoplasma
gondii
caus
opportunist
infect
particularli
sever
immunocompromis
patient
infant
neonat
current
antiparasit
drug
teratogen
caus
hypersensitivitybas
toxic
side
effect
especi
prolong
treatment
furthermor
recent
emerg
drugresist
toxoplasmosi
reduc
therapeut
impact
drug
effort
develop
recombin
antibodi
therapeut
altern
panel
affinitymatur
gondii
tachyzoitespecif
singlechain
variabl
fragment
scfv
antibodi
select
phage
display
bioinformat
analysi
affin
optim
attempt
introduc
point
mutat
hotspot
within
light
chain
complementaritydetermin
region
strategi
yield
four
mutat
scfv
sequenc
parent
scfv
use
produc
five
mousehuman
chimer
igg
nicotiana
benthamiana
plant
yield
mgkg
plant
tissu
immunolog
analysi
confirm
specif
bind
plantderiv
antibodi
gondii
tachyzoit
vitro
efficaci
demonstr
abil
inhibit
invas
human
fibroblast
impair
parasit
infect
novel
recombin
antibodi
could
therefor
suitabl
develop
plantderiv
immunotherapeut
intervent
toxoplasmosi
molecular
character
human
monoclon
antibodi
specif
sever
hiv
protein
analysi
famili
express
immunolog
letter
doi
foster
sj
farner
nl
lipski
pe
somat
hypermut
human
immunoglobulin
heavi
chain
gene
target
rgyw
motif
dna
strand
hansen
mh
nielsen
hv
ditzel
hj
transloc
intracellular
antigen
surfac
medullari
breast
cancer
cell
earli
apoptosi
allow
antigendriven
antibodi
respons
elicit
tumorinfiltr
b
cell
toxoplasma
gondii
oblig
intracellular
protozoan
parasit
invad
colon
almost
nucleat
cell
result
lifelong
chronic
infect
current
affect
world
popul
manger
hehl
boothroyd
montoya
liesenfeld
toxoplasmosi
infect
immunocompet
individu
usual
selflimit
quickli
resolv
immun
system
thu
prevent
acut
infect
howev
gondii
caus
sever
neurolog
birth
defect
transmit
congenit
primari
infect
devast
lifelong
impact
child
health
develop
later
product
holliman
parasit
also
opportunist
pathogen
affect
immunocompromis
individu
aid
patient
caus
reactiv
latent
infect
fulmin
diseas
usual
manifest
toxoplasm
enceph
chorioretin
israelski
et
al
luft
et
al
holliman
hunter
sibley
mcleod
et
al
current
goldstandard
drug
toxoplasmosi
caus
inflammatori
side
effect
gener
unafford
less
develop
nation
mui
et
al
drug
also
teratogen
therefor
use
first
trimest
pregnanc
goldstein
montoya
remington
factor
combin
emerg
drugresist
gondii
strain
sim
creat
press
need
novel
antiparasit
therapi
passiv
immun
use
altern
strategi
particularli
diseas
character
chronic
lifelong
infect
vaccin
strategi
enjoy
littl
success
parasit
evad
immun
system
major
challeng
establish
steril
immun
elus
vaccin
endpoint
lim
othman
although
prevent
vaccin
desir
lethal
case
toxoplasmosi
reactiv
infect
immunocompromis
patient
insuffici
cellular
immun
luft
remington
recombin
antibodi
suitabl
context
passiv
immun
inhibit
pathogenesi
either
replac
adjunct
convent
intervent
neutral
antibodi
gondii
alreadi
demonstr
feasibl
strategi
cha
et
al
fu
et
al
plant
emerg
competit
express
platform
recombin
antibodi
reduc
cost
product
hein
fischer
eman
fischer
et
al
twyman
schillberg
fischer
kim
et
al
plant
also
achiev
effici
assembl
complex
multimer
antibodi
close
resembl
produc
mammalian
system
risk
exposur
animalderiv
product
pathogen
recombin
antibodi
deriv
murin
sourc
induc
undesir
human
antimous
antibodi
respons
strategi
overcom
issu
includ
antibodi
human
mateo
et
al
phagedisplay
chain
shuffl
kupper
et
al
chimer
antibodi
construct
complementaritydetermin
region
cdr
graft
vaquero
et
al
previou
studi
demonstr
success
product
antiparasit
antibodi
plant
potenti
new
therapeut
treatment
voepel
et
al
chen
et
al
fragoso
et
al
studi
aim
develop
convert
gondiispecif
singlechain
variabl
fragment
scfv
antibodi
murin
sourc
chimer
human
igg
produc
function
fullsiz
molecul
express
nicotiana
benthamiana
show
plantderiv
chimer
antibodi
specif
bind
parasit
reduc
infect
parasit
cell
cultur
procedur
carri
class
ii
type
lamina
flow
hood
fibroblast
cell
line
deriv
human
foreskin
fibroblast
hff
obtain
atcc
cell
cultur
dulbecco
modifi
eagl
medium
dmem
supplement
vv
fetal
calf
serum
fc
two
mm
lglutamin
unitsml
penicillin
mgml
streptomycin
cell
confluent
maintain
infect
medium
vv
fc
cell
inocul
gondii
tachyzoit
cell
incub
humidifi
cell
cultur
chamber
c
co
atmospher
h
gondii
tachyzoit
egress
host
cell
cell
scrapper
use
disrupt
cell
contain
rosett
tachyzoit
tachyzoit
pass
needl
centrifug
min
pellet
contain
tachyzoit
resuspend
five
ml
infect
medium
filter
threemm
nucleopor
polycarbon
filter
membran
ge
healthcar
life
scienc
marlborough
usa
remov
cell
debri
filter
parasit
quantifi
hemocytomet
trypan
blue
stain
sambrook
russel
nativ
solubl
antigen
cat
lyse
gondii
acquir
commerci
meridian
life
scienc
memphi
tn
usa
three
balbc
mice
week
old
immun
subcutan
inject
gondii
rh
tachyzoit
emulsifi
freund
complet
adjuv
cat
sigmaaldrich
st
loui
mo
usa
ratio
interv
week
day
day
follow
second
booster
inject
day
amount
tachyzoit
time
without
adjuv
immun
mice
bled
day
second
booster
serum
test
presenc
gondiispecif
igg
antibodi
immunoblot
analysi
towbin
staehelin
gordon
methodolog
carri
accord
univers
malaya
anim
care
use
ethic
committe
acuc
guidelin
experiment
protocol
approv
acuc
univers
malaya
clearanc
number
r
follow
detect
gondiispecif
igg
antibodi
mous
spleen
harvest
snapfrozen
liquid
nitrogen
store
c
total
rna
prepar
homogen
mous
spleen
use
rneasi
mini
kit
qiagen
gmbh
hilden
germani
accord
manufactur
instruct
mrna
purifi
use
micropoli
purist
tm
small
scale
mrna
purif
kit
ambion
foster
citi
ca
usa
mg
use
templat
cdna
synthesi
superscript
tm
iii
revers
transcriptas
invitrogen
carlsbad
ca
usa
accord
manufactur
protocol
typic
mg
mrna
use
per
reaction
firststrand
cdna
synthesi
prime
oligo
dt
primer
invitrogen
carlsbad
ca
usa
result
cdna
use
templat
amplif
murin
igg
variabl
heavi
v
h
light
v
l
chain
gene
region
previous
describ
nathan
et
al
incorpor
flank
sfii
noti
restrict
site
v
l
v
h
domain
respect
primer
sequenc
list
tabl
primer
combin
design
amplifi
known
mous
antibodi
sequenc
thu
gener
polyclon
pool
v
region
fragment
total
vk
region
pcr
volum
carri
amplifi
k
light
chain
lc
variabl
region
follow
mm
mscvk
vk
sensesfii
primer
mix
mm
mscjk
vk
antisens
primer
mix
two
ml
firststrand
cdna
mm
dntp
mix
promega
madison
wi
usa
pcr
buffer
u
dynazym
tm
ii
dna
polymeras
finnzym
vantaa
finland
vl
gene
region
amplif
prepar
use
one
set
forward
revers
primer
set
except
primer
mix
substitut
vl
sensesfii
mscjklb
vl
antisenseshort
linker
primer
four
vl
pcr
reaction
prepar
v
h
gene
region
amplifi
use
combin
forward
primer
three
revers
primer
gener
total
v
h
reaction
prepar
describ
v
h
region
pcr
reaction
includ
mscvh
v
h
sens
mscg
v
h
antisensenoti
primer
mix
amplif
v
h
region
igm
amplif
began
c
min
follow
cycl
c
c
c
final
extens
step
c
min
pcr
product
purifi
use
qiaquick
gel
extract
kit
qiagen
gmbh
hilden
germani
v
h
v
l
code
sequenc
fuse
use
flank
primer
mscf
ggg
ccc
agc
cgg
ccg
agc
rscb
tgc
ggc
cgc
act
agt
gac
spliceoverlap
extens
pcr
soepcr
produc
scfv
fragment
scfv
assembl
reaction
compris
one
mm
mscf
primer
one
mm
rscb
primer
ng
v
h
v
l
code
sequenc
one
mm
dntp
mix
amplif
buffer
one
mm
mgso
pcr
x
enhanc
solut
one
u
platinum
pfx
dna
polymeras
invitrogen
carlsbad
ca
usa
reaction
compris
seven
cycl
c
min
c
c
c
min
follow
cycl
pullthrough
reaction
c
min
c
c
min
follow
final
extens
step
c
min
result
polyclon
pool
scfv
fragment
sequenti
digest
sfii
noti
transfer
phagemid
vector
ge
healthcar
life
scienc
marlborough
usa
ligat
product
introduc
electrocompet
escherichia
coli
cell
electropor
kv
mf
time
constant
ms
five
set
scfv
electropor
transform
carri
gener
combinatori
scfv
librari
antibodi
express
fusion
minor
phage
coat
protein
piii
rescu
helper
phage
phagescfv
display
librari
incub
gondii
tachyzoit
preblock
microcentrifug
tube
c
h
rotat
tachyzoit
cell
pellet
centrifug
c
min
supernat
discard
cell
vortex
five
time
toddhewitt
broth
thb
contain
vv
thbt
centrifug
bound
phage
elut
resuspend
cell
ml
glycinehcl
ph
c
min
neutral
ad
ml
triscl
ph
phage
eluat
introduc
logphas
e
coli
cell
plate
super
optim
broth
ampicillin
glucos
sobag
overnight
c
dilut
phage
output
titer
phage
output
titer
calcul
mean
triplic
set
dilut
determin
number
phage
captur
cell
remain
phageinfect
e
coli
suspens
plate
larg
sobag
plate
also
incub
c
overnight
obtain
singl
coloni
gondiibind
scfv
clone
scfv
clone
verifi
pcr
presenc
fulllength
scfv
sequenc
fingerprint
mvai
thermo
fisher
scientif
waltham
usa
fulllength
scfv
gene
uniqu
fingerprint
pattern
select
clone
sequenc
use
dideoxi
method
sequenc
primer
pair
ge
healthcar
life
scienc
marlborough
usa
phage
rescu
monoclon
fulllength
scfv
clone
achiev
use
interferenceresist
helper
phage
stratagen
san
diego
ca
usa
recombin
phage
suspens
clone
pfu
block
wv
bovin
serum
albumin
bsa
incub
gondii
tachyzoit
cellsreact
scfv
clone
also
test
bind
hff
cell
cellsreact
control
reaction
incub
c
h
rotat
centrifug
wash
phageelut
step
reinfect
step
carri
describ
mean
sampl
neg
control
compar
use
onetail
wilcoxonmannwhitney
statist
test
h
h
sigmaplot
systat
softwar
inc
san
jose
ca
usa
exact
p
valu
wilcoxon
mannwhitney
statist
comput
use
analyseit
statist
analysi
softwar
microsoft
excel
fulllength
v
h
v
l
chain
sequenc
number
accord
intern
immunogenet
imgt
uniqu
number
scheme
lefranc
et
al
analyz
use
vquest
imgtcinesfrtextesvquest
determin
cdr
germlin
origin
targetunrel
peptid
tup
motif
sequenc
redund
identifi
use
scanner
report
targetunrel
peptid
sarotup
mimodb
structur
model
accomplish
use
webbas
antibodi
model
softwar
rosetta
antibodi
structur
predict
server
provid
depart
chemic
biomolecular
engin
john
hopkin
univers
http
antibodygraylabjhuedu
sircar
kim
gray
protocol
integr
ab
initio
cdr
loop
model
simultan
optim
cdr
backbon
dihedr
angl
rel
orient
v
l
v
h
first
rank
predict
use
scfv
model
analysi
superimposit
scfv
molecular
model
gener
pymol
window
candid
scfvphage
particl
use
infect
e
coli
cell
nonsuppressor
strain
iptginduc
express
antibodi
fragment
solubl
scfv
antibodi
extract
bacteri
periplasm
previous
describ
barba
et
al
periplasm
extract
analyz
wv
sdspage
laemmli
transfer
nitrocellulos
membran
probe
overnight
c
antietag
primari
antibodi
abcam
cambridg
uk
dilut
trisbuff
salin
tb
wv
skim
milk
blot
wash
three
time
tbst
tb
vv
incub
horseradish
peroxidaseconjug
antirabbit
igg
secondari
antibodi
cat
sigmaaldrich
st
loui
mo
usa
dilut
wv
skim
milk
h
gentl
agit
three
wash
tbst
signal
detect
supersign
west
pico
ecl
substrat
thermo
fisher
scientif
waltham
usa
antibodi
hotspot
region
cdr
identifi
use
vquest
hotspot
motif
rgyw
scfv
v
l
chosen
introduct
random
mutat
produc
affinitymatur
scfv
antibodi
librari
complet
overlap
sens
antisens
dna
oligom
design
gener
librari
random
four
nucleotid
two
consecut
amino
acid
hotspot
prevent
introduct
stop
codon
follow
degener
oligom
use
random
sequenc
underlin
bold
ergyw
fwd
sens
gcc
agt
cag
gat
gtg
vn
nct
gct
gta
ergyw
rev
antisens
tac
agc
agn
snb
cac
atc
ctg
act
ggc
c
v
c
g
c
g
b
c
g
affin
matur
reaction
carri
use
quickchang
lightn
sitedirect
mutagenesi
kit
stratagen
san
diego
ca
usa
sitedirect
mutagenesi
oligonucleotid
adaptor
gener
degener
oligom
improv
reaction
perform
equimolar
amount
degener
oligonucleotid
ergyw
fwd
ergyw
rev
resuspend
anneal
buffer
mm
trishcl
ph
mm
nacl
heat
c
min
cool
room
temperatur
overnight
form
oligonucleotid
duplex
follow
gener
degener
adaptor
mutagenesi
pcr
reaction
carri
use
ng
phagemid
templat
pmol
degener
dna
adaptor
pmol
ng
degener
dna
oligom
ergyw
fwd
ergyw
rev
scfv
templat
dna
adaptor
mix
quikchang
lightn
enzym
agil
technolog
santa
clara
ca
usa
compon
reagent
accord
manufactur
protocol
reaction
volum
heat
c
min
follow
cycl
c
c
c
min
final
extens
step
c
min
mutagenesi
pcr
product
digest
remov
parent
phagemid
dsdna
precipit
ethanol
introduc
gold
ultracompet
cell
stratagen
san
diego
ca
usa
accord
manufactur
protocol
transform
clone
verifi
coloni
pcr
sequenc
check
success
sequenc
diversif
sequenc
align
use
bioedit
hall
isol
plasmid
dna
introduc
chemicallycompet
e
coli
cell
tu
et
al
rescu
use
helper
phage
stratagen
san
diego
ca
usa
barba
et
al
affinitymatur
scfv
librari
prepar
phage
rescu
precipit
polyethylen
glycol
block
wv
bsa
ratio
biopan
recombin
phage
cfu
mutat
librari
incub
triplic
gondii
tachyzoit
cell
preblock
microcentrifug
tube
mixtur
rotat
four
rpm
c
h
helper
phage
neg
control
cell
pellet
centrifug
c
min
supernat
discard
cell
resuspend
cold
thbt
vortex
incub
min
rpm
c
wash
step
repeat
consecut
round
bound
phage
elut
resuspend
cell
glycinehcl
ph
describ
reinfect
elut
phage
titer
determin
quantiti
captur
phage
glycerol
stock
eluat
prepar
store
c
elut
recombin
phage
use
reinfect
logphas
e
coli
cell
plate
sobag
medium
overnight
incub
c
singl
coloni
pick
clone
sequenc
character
captur
affinitymatur
scfv
antibodi
five
uniqu
affinitymatur
phagescfv
clone
rescu
use
interferenceresist
helper
phage
stratagen
san
diego
ca
usa
assess
biopan
gondii
tachyzoit
recombin
phage
suspens
clone
mean
titer
cfuml
block
wv
bsa
incub
gondii
tachyzoit
cell
per
reaction
describ
v
h
sequenc
scfv
insert
plant
express
vector
ptrakchc
upstream
cc
region
use
restrict
site
bsphi
noti
wherea
v
l
sequenc
insert
ptrakclc
upstream
ck
region
use
restrict
site
ncoi
noti
ptra
plant
express
vector
deriv
ppam
genbank
ptra
construct
introduc
agrobacterium
tumefacien
electropor
eppendorf
hamburg
germani
use
standard
set
kv
ms
mf
transform
store
vv
glycerol
suspens
c
bacteri
suspens
prepar
agroinfiltr
piotrzkowski
schillberg
rasch
dilut
acetosyringoneinduc
bacteria
od
infiltr
medium
combin
ptrakchc
ptrakclc
transform
mix
ratio
prior
infiltr
suspens
five
hc
lc
combin
correspond
five
scfv
variant
coagroinfiltr
n
benthamiana
leav
standard
syring
infiltr
daoust
et
al
plant
incub
phytotron
day
harvest
infiltr
leav
weigh
grind
fine
powder
liquid
nitrogen
mortar
pestl
total
solubl
protein
extract
two
ml
pb
contain
mm
sodium
disulfid
per
gram
leaf
materi
cell
debri
remov
filter
miracloth
merck
millipor
billerica
usa
follow
centrifug
min
c
supernat
adjust
mm
nacl
allow
cool
ice
min
centrifug
pass
syring
filter
chimer
igg
purifi
use
protein
sepharos
ge
healthcar
life
scienc
marlborough
usa
hehl
et
al
desalt
column
ge
healthcar
life
scienc
marlborough
usa
use
manufactur
graviti
protocol
purifi
desalt
fraction
analyz
reduc
nonreduc
sdspage
coomassi
stain
determin
antibodi
integr
extract
igg
detect
use
alkalin
phosphatas
ap
conjug
human
fcspecif
jackson
immunoresearch
laboratori
inc
west
grove
pa
usa
human
k
lcspecif
sigmaaldrich
st
loui
mo
usa
antibodi
signal
develop
use
nbt
substrat
purifi
igg
antibodi
concentr
determin
use
qubit
fluoromet
thermo
fisher
scientif
waltham
usa
toxoplasma
gondii
antigen
cat
meridian
life
scienc
memphi
tn
usa
coat
onto
highbind
enzymelink
immunosorb
assay
elisa
plate
dynex
technolog
chantilli
va
usa
concentr
mg
per
well
pb
overnight
c
plate
wash
three
time
pb
block
wv
bsa
pb
h
room
temperatur
hff
cell
lysat
mous
ascit
cat
sigmaaldrich
st
loui
mo
usa
control
coat
concentr
mg
per
well
process
recombin
igg
purifi
transform
plant
dilut
work
concentr
two
mgml
wv
bsa
test
antigen
h
room
temperatur
elisa
plate
wash
four
time
pbst
detect
bind
antibodi
hrpconjug
antihuman
fc
dilut
h
room
temperatur
plate
wash
three
time
pbst
follow
two
wash
pb
assay
develop
tm
ultra
tmb
elisa
substrat
thermo
fisher
scientif
waltham
usa
accord
manufactur
instruct
reaction
stop
min
h
read
taken
od
nm
use
micropl
reader
tecan
maennedorf
switzerland
immunoblot
analysi
gondii
total
antigen
lysat
cat
meridian
life
scienc
memphi
tn
usa
either
prepar
boil
reduc
sampl
buffer
wv
sd
vv
glycerol
mm
triscl
ph
one
mm
edta
mgml
bromophenol
blue
vv
min
mix
nativepag
tm
sampl
buffer
thermo
fisher
scientif
waltham
usa
fraction
wv
acrylamid
gel
gel
blot
onto
nitrocellulos
membran
block
wv
bsa
tbst
blot
membran
cut
strip
probe
chimer
igg
concentr
one
mgml
overnight
c
bound
igg
individu
strip
detect
use
apconjug
antihuman
fc
antibodi
jackson
immunoresearch
laboratori
inc
west
grove
pa
usa
treat
strip
develop
western
blue
stabil
substrat
ap
promega
madison
wi
usa
acidwash
coverslip
treat
wv
polyllysin
solut
cat
sigmaaldrich
st
loui
mo
usa
min
room
temperatur
drain
dri
cover
freshlyharvest
parasit
approxim
cell
per
coverslip
cell
allow
attach
h
c
follow
fixat
formaldehyd
min
ice
sampl
block
wv
bsa
pb
visual
bind
chimer
antibodi
surfac
intact
parasit
fix
coverslip
incub
chimer
ig
antibodi
five
mgml
h
c
wash
five
time
pbst
stain
alexafluor
jackson
immunoresearch
laboratori
inc
west
grove
pa
usa
h
coverslip
mount
prolong
gold
thermo
fisher
scientif
waltham
usa
cure
h
stain
step
conduct
antibodi
dilut
bsa
pb
coverslip
incub
buffer
control
secondari
antibodi
includ
neg
control
result
visual
use
len
olympu
microscop
parasit
invas
assay
carri
describ
tyler
boothroyd
minor
modif
briefli
wash
rh
parasit
incub
dmem
vv
fc
supplement
mgml
antibodi
volum
buffer
control
pb
incub
c
min
rotat
invas
encourag
incub
coverslip
confluent
monolay
hff
cell
h
c
co
incub
tachyzoit
ml
per
coverslip
sixwel
plate
infect
monolay
gentli
wash
twice
pb
fix
formaldehyd
extracellular
parasit
stain
rabbit
antit
gondii
polyclon
antiserum
follow
alexafluor
secondari
antibodi
infect
monolay
first
permeabil
triton
pb
block
bsa
parasit
stain
goat
antit
gondii
polyclon
antiserum
follow
alexafluor
secondari
antibodi
primari
alexafluorconjug
secondari
antibodi
obtain
commerci
abcam
cambridg
uk
coverslip
mount
prolong
gold
contain
dapi
thermo
fisher
scientif
waltham
usa
overnight
number
green
intracellular
extracellular
red
extracellular
tachyzoit
score
randomlyselect
field
two
separatelymount
coverslip
differ
antibodi
treatment
visual
use
len
olympu
microscop
digit
imag
acquir
analyz
use
nikon
ni
element
softwar
result
repres
data
least
two
independ
experi
attach
assay
proceed
describ
invas
assay
except
hff
monolay
coverslip
prefix
paraformaldehyd
parasit
incub
freshlyreleas
tachyzoit
incub
monoclon
antibodi
mgml
igg
dmem
per
tachyzoit
separ
min
c
rotat
pretreat
tachyzoit
allow
attach
fix
monolay
sixwel
plate
min
c
attach
parasit
stain
rabbit
antit
gondii
polyclon
antiserum
follow
alexafluor
secondari
antibodi
wash
fix
mount
number
attach
parasit
determin
random
field
magnif
assay
carri
triplic
tachyzoit
pretreat
c
min
infect
individu
monoclon
antibodi
concentr
mgml
confluent
monolay
hff
cell
grown
sixwel
plate
seed
tachyzoit
per
well
h
c
monolay
wash
replenish
fresh
dmem
incub
day
c
monolay
fix
absolut
ethanol
min
stain
min
crystal
violet
solut
describ
et
al
imag
captur
use
nikon
eclips
invert
microscop
magnif
total
random
field
per
coverslip
captur
treatment
plaqu
area
measur
use
nikon
ni
element
softwar
assay
carri
triplic
biopan
phagescfv
display
librari
isol
gondiispecif
antibodi
mice
immun
gondii
tachyzoit
period
week
found
seroposit
infect
immunoblot
fig
mice
sacrif
harvest
spleen
scfv
antibodi
fragment
construct
amplifi
v
h
v
l
gene
fragment
isol
splenic
mrna
fuse
v
h
v
l
region
soepcr
interven
sevenaminoacid
flexibl
linker
sequenc
ggssrss
fig
least
separ
round
pcr
carri
construct
scfv
fragment
increas
librari
size
divers
scfv
fragment
clone
phagemid
vector
express
phage
display
scfv
librari
result
complex
independ
transform
antibodi
appropri
bind
activ
select
singl
round
solutionphas
biopan
gondii
tachyzoit
multipl
round
biopan
undesir
result
enrich
mostli
truncat
antibodi
fragment
stop
codon
variabl
region
fig
polyclon
biopan
scfv
librari
sixfold
higher
bind
titer
parasit
cell
unpan
scfv
librari
indic
enrich
gondiibind
scfv
biopan
result
select
four
differ
antibodi
fragment
gondii
bind
activ
name
scfv
genbank
id
genbank
id
genbank
id
genbank
id
correspond
amino
acid
sequenc
analyz
use
imgt
vquest
imgtcinesfrtextesvquest
tabl
antibodi
germlin
align
provid
fig
base
analysi
diverg
select
variabl
domain
sequenc
germlin
counterpart
summar
tabl
sequenc
diverg
germlin
repertoir
reflect
somat
hypermut
event
b
cell
affin
matur
maclennan
li
et
al
indirectli
indic
high
affin
andor
efficaci
vquest
analysi
show
scfv
contain
amino
acid
point
mutat
cdr
six
residu
total
v
h
v
l
chain
local
tabl
usual
contribut
signific
contact
antibodyantigen
interact
contrast
scfv
contain
fewer
deviat
germlin
sequenc
potenti
indic
lower
degre
affin
matur
sequenc
analyz
use
sarotup
http
immunetcnsarotup
exclud
falseposit
antibodi
fragment
huang
et
al
indic
scfv
contain
tup
motif
tabl
phage
rescu
use
produc
recombin
phage
particl
fuse
select
scfv
clone
monoclon
biopan
assay
scfvphage
clone
titer
biopan
input
output
titer
respect
elut
scfv
tachyzoit
determin
recoveri
fig
begin
note
dna
nt
amino
acid
aa
sequenc
recombin
scfvphage
isol
biopan
gondii
tachyzoit
align
compar
analyz
closest
homolog
vregion
germlin
counterpart
vregion
jregion
ident
level
determin
vquest
program
analysi
cdr
mutat
event
manual
identifi
calcul
align
percentag
total
number
aa
residu
differ
germlin
aa
sequenc
origin
presum
produc
somat
hypermut
b
cell
exposur
antigen
total
number
aa
residu
mutat
germlin
sequenc
origin
amino
acid
residu
mutat
present
amino
acid
residu
mutat
present
averag
phagescfv
input
titer
cfuml
clone
found
scfv
highest
gondii
bind
titer
cfuml
scfv
lowest
cfuml
howev
statist
analysi
reveal
signific
differ
abil
three
four
isol
scfv
bind
gondii
hff
cell
p
n
despit
initi
promis
bind
titer
p
p
p
indic
antibodi
specif
parasit
target
remain
antibodi
scfv
promis
show
signific
gondii
bind
specif
p
n
fivefold
higher
bind
titer
parasit
compar
hff
p
fig
antibodi
specif
take
preced
titer
indic
bona
fide
antigenspecif
bind
result
consist
bioinformat
analysi
show
scfv
contain
tup
less
matur
like
nonspecif
contrast
scfv
combin
uniqu
antibodi
cdr
sequenc
high
target
specif
justifi
character
function
valid
analyz
structur
scfv
use
rosetta
antibodi
structur
predict
server
sircar
kim
gray
allow
gener
threedimension
molecular
model
germlin
counterpart
structur
diverg
figur
monoclon
scfv
bind
titer
gondii
tachyzoit
hff
candid
scfv
antibodi
clone
biopan
select
test
determin
differenti
bind
target
parasit
gondii
black
human
cell
line
hff
gray
phagedisplay
scfv
clone
incub
either
parasit
hff
cell
equival
pfu
h
wash
elut
asterisk
denot
statist
signific
differ
scfv
bind
gondii
p
untransform
phage
bind
titer
shown
neg
control
rule
background
bind
error
bar
repres
standard
error
mean
sem
duplic
experi
fullsiz
doi
scfv
germlin
counterpart
investig
molecular
superimposit
structur
align
superimpos
ribbon
diagram
repres
germlin
scfv
vregion
show
signific
structur
chang
antigencombin
site
fig
although
region
scfv
twice
mani
mutat
four
substitut
region
two
substitut
molecular
superimposit
reveal
greatest
structur
deviat
locat
within
heavi
chain
hc
loop
rather
structur
align
show
greatest
deviat
point
v
l
chain
thr
germlin
residu
mutat
tyr
scfv
root
mean
squar
deviat
rmsd
v
h
chain
cdr
region
greatest
deviat
point
ala
germlin
residu
mutat
asp
scfv
fragment
rmsd
molecular
structur
indic
six
somat
mutat
rel
germlin
counterpart
tyr
thr
pro
ala
trp
fix
within
loop
therebi
potenti
involv
antigen
bind
nine
mutat
residu
locat
vernier
posit
make
direct
contact
antigen
higher
percentag
amino
acid
residu
chang
within
cdr
compar
framework
region
mutat
within
cdr
within
framework
region
order
improv
affin
scfv
gondii
rgyw
hotspot
motif
r
g
c
w
modifi
vitro
sitedirect
mutagenesi
result
affinitymatur
antibodi
librari
complex
independ
clone
affinitymatur
librari
subject
round
biopan
antibodi
clone
elut
parasit
cell
yield
four
distinct
clone
select
character
argala
argthr
argser
leuthr
substitut
posit
v
l
tabl
multipl
codon
usag
also
observ
clone
suggest
strong
select
specif
replac
residu
parent
scfv
select
gener
chimer
igg
antibodi
chimer
igg
antibodi
construct
transfer
v
h
v
l
region
parent
scfv
four
affinitymatur
deriv
binari
plant
express
vector
ptrakchc
ptrakclc
contain
human
cc
ck
domain
respect
tumefacien
cultur
separ
transform
hc
lc
construct
coinfiltr
n
benthamiana
leav
produc
fulllength
igg
molecul
fig
subsequ
purif
protein
affin
chromatographi
produc
mg
purifi
antibodi
per
gram
infiltr
fresh
leaf
tissu
specif
mgg
mgg
mgg
mgg
mgg
result
antibodi
prepar
averag
puriti
estim
sdspage
gel
densitometri
use
imag
j
reduc
condit
antibodi
hc
lc
visibl
eluat
lane
expect
size
kda
respect
nonreduc
condit
antibodi
appear
higher
molecular
weight
band
size
approxim
kda
consist
tetramer
form
intact
igg
along
tetramer
igg
sever
multimer
antibodi
band
observ
immunoblot
reveal
minor
degrad
antibodi
howev
intact
tetramer
igg
form
show
stronger
band
intens
valid
analyt
hplc
major
speci
indirect
elisa
use
quantifi
bind
recombin
antibodi
gondii
lysat
detergentsolubil
hff
lysat
control
mous
ascit
standard
commerci
prepar
incorpor
nonspecif
control
fig
five
recombin
igg
show
signific
bind
gondii
compar
control
antigen
howev
contrari
expect
parent
antibodi
show
higher
bind
activ
variant
select
affinitymatur
antibodi
librari
antibodi
character
detail
immunoblot
analysi
use
reduc
nonreduc
fraction
gondii
lysat
fig
found
igg
parent
show
detect
bind
parasit
antigen
reduc
nonreduc
fraction
wherea
igg
igg
consist
show
detect
bind
fraction
lysat
fraction
reduc
sdspage
three
posit
antibodi
parent
plu
highlight
multipl
band
promin
repres
antigen
kda
nonreduc
condit
antibodi
detect
antigen
kda
igg
gener
particularli
weak
bind
signal
immunofluoresc
assay
ifa
carri
visual
bind
chimer
antibodi
parasit
surfac
protein
nativ
context
fig
despit
variabl
result
obtain
elisa
immunoblot
experi
observ
specif
immunostain
igg
surfac
gondii
tachyzoit
fig
ambigu
across
differ
immunoassay
may
reflect
differ
abund
fold
parasit
antigen
use
lyse
detergentsolubil
parasit
antigen
elisa
immunoblot
nativ
antigen
present
intact
cell
ifa
neg
control
yield
neglig
bind
signal
experi
anticip
final
investig
abil
chimer
antibodi
inhibit
invas
human
fibroblast
use
redgreen
invas
assay
fig
found
three
chimer
igg
caus
signific
declin
parasit
invas
efficaci
rel
untreat
control
name
parent
wherea
igg
show
signific
inhibit
invas
fig
order
determin
whether
inhibit
parasit
invas
reflect
impair
parasit
bind
host
cell
measur
abil
iggtreat
figur
elisa
chimer
gondiispecif
igg
specif
chimer
antibodi
parent
lyse
gondii
antigen
shown
elisa
parallel
test
hff
lysat
murin
ascit
control
elisa
plate
coat
mgml
antigen
control
hrpconjug
secondari
antibodi
includ
intern
neg
control
antibodi
nc
error
bar
indic
standard
deviat
mean
triplic
experi
fullsiz
doi
parasit
bind
host
cell
fix
paraformaldehyd
render
rigid
resist
invas
except
treat
parasit
show
partial
reduct
host
cell
attach
compar
untreat
control
attach
score
differ
significantli
igg
inhibit
shown
fig
igg
show
littl
improv
abil
block
parasit
attach
compar
untreat
control
inhibit
plaqu
assay
use
valid
effect
chimer
igg
invas
assay
recapitul
step
lytic
cycl
remark
parent
igg
achiev
reduct
mean
plaqu
area
compar
untreat
control
fig
parasit
treat
antibodi
form
substanti
smaller
plaqu
compar
control
even
low
igg
concentr
mgml
fig
collect
result
demonstr
plantderiv
igg
particularli
parent
highli
efficaci
ligand
inhibit
invas
host
cell
gondii
vitro
current
studi
demonstr
develop
evalu
five
mousehuman
chimer
igg
base
select
mutat
gondii
tachyzoitespecif
scfv
sequenc
chimer
igg
express
n
benthamiana
plant
igg
shown
bind
specif
gondii
tachyzoit
inhibit
invas
human
fibroblast
suggest
great
pharmaceut
potenti
plantderiv
antibodi
toxoplasmosi
toxoplasma
gondii
opportunist
pathogen
caus
sever
lethal
infect
individu
reduc
cellular
immun
exampl
infant
neonat
immunocompromis
adult
humor
cellular
immun
respons
must
act
concert
effect
resist
toxoplasmosi
mice
defici
b
cell
suscept
lethal
toxoplasmosi
chronic
infect
phase
mainli
due
unrestrict
parasit
prolifer
brain
lung
caus
widespread
tissu
necrosi
kang
remington
suzuki
although
cell
ifnc
import
mediat
host
immun
respons
gondii
specif
antibodi
produc
b
cell
essenti
longterm
resist
kang
remington
suzuki
therefor
neutral
antibodi
import
therapeut
option
diseas
recent
demonstr
west
nile
viru
infect
oliph
et
al
ebola
viru
diseas
pettitt
et
al
specif
antibodi
gondii
surfac
protein
live
cell
shown
strong
potenti
inhibitori
activ
vitro
vivo
carruth
gid
sibley
figur
igg
treatment
gondii
parasit
inhibit
invas
freshli
harvest
parasit
pretreat
buffer
control
nc
mgml
chimer
antibodi
allow
infect
hff
monolay
h
normal
cultur
condit
number
invas
parasit
determin
use
differenti
stain
extracellular
red
red
green
intracellular
parasit
green
deterg
permeabil
b
invas
efficaci
nc
iggtreat
parasit
immunofluoresc
microscopi
show
signific
decreas
number
invas
parasit
green
parasit
remain
outsid
cell
red
red
green
compar
nc
c
number
intracellular
parasit
score
randomlyselect
field
two
coverslip
igg
test
nc
tachyzoit
attach
paraformaldehydefix
fibroblast
incub
chimer
igg
compar
nc
e
f
plaqu
assay
hff
monolay
infect
tachyzoit
treat
plantderiv
igg
antibodi
mgml
compar
tachyzoit
treat
nc
allow
grow
day
g
size
lysi
plaqu
measur
invas
level
follow
antibodi
treatment
shown
mean
percentag
rel
nc
standard
deviat
parasit
attach
host
cell
score
antibodi
treatment
shown
mean
score
standard
deviat
invas
assay
carri
duplic
wherea
attach
plaqu
assay
carri
triplic
asterisk
doubl
asterisk
denot
statist
signific
reduct
parasit
invas
rel
nt
student
ttest
p
p
fullsiz
doi
hehl
liu
et
al
fu
et
al
therefor
pan
phagescfv
librari
live
gondii
tachyzoit
use
stringent
select
combin
bioinformat
analysi
isol
promis
parasitespecif
scfv
specif
scfv
isol
rel
small
scfv
librari
independ
transform
gener
singl
ligat
reaction
gener
larger
scfv
librari
magnitud
independ
transform
could
possibl
yield
specif
scfv
antibodi
would
requir
approxim
ten
ligat
reaction
follow
electrotransform
barba
et
al
scfv
antibodi
format
ideal
phage
displaybas
screen
procedur
monoval
tend
unstabl
kupper
et
al
therefor
convert
scfv
antibodi
fulllength
igg
produc
transient
express
n
benthamiana
plant
also
attempt
vitro
affin
matur
v
l
sitedirect
mutagenesi
detail
function
analysi
mutant
variant
demonstr
signific
improv
achiev
perform
parent
antibodi
use
approach
mutant
abl
bind
specif
gondii
tachyocyt
crossreact
human
cell
murin
ascit
two
variant
show
similar
efficaci
parasit
invas
assay
compar
parent
igg
vitro
perform
variant
poor
lack
antibodi
improv
achiev
affin
matur
strategi
could
due
inher
limit
low
signaltonois
ratio
equilibrium
select
method
requir
antigen
level
rang
antibodi
k
use
tachyzoit
cell
nativ
antigen
also
like
contribut
high
nois
select
phase
owe
complex
cell
surfac
landscap
similar
work
futur
improv
antibodi
affin
consid
use
nonstochast
methodolog
lookthrough
mutagenesi
systemat
gener
singl
amino
acid
substitut
cdr
posit
comput
design
predict
bind
affin
calcul
bind
freeenergi
antibodi
model
gener
antibodi
mutant
method
combin
use
competit
bind
strategi
select
phase
could
enabl
enrich
clone
slowerdisassoci
kinet
parent
antibodi
result
improv
affin
phagescfv
display
librari
often
subject
multipl
round
select
purifi
antigen
ridgway
et
al
giordano
et
al
hof
et
al
eisenhardt
et
al
howev
found
multipl
round
biopan
gondii
cell
result
recoveri
predominantli
truncat
protein
instead
fulllength
scfv
previous
report
antigen
yan
ko
qi
liu
et
al
et
al
includ
select
fab
antibodi
fragment
gondii
protein
fu
et
al
wholecel
biopan
challeng
heterogen
sticki
cell
surfac
tend
trap
nonspecif
binder
problem
compound
propag
nonspecif
binder
subsequ
amplif
round
kramer
et
al
howev
offset
advantag
screen
nativ
antigen
conform
includ
carbohydr
epitop
context
complex
cellsurfac
landscap
siegel
therefor
use
singl
round
select
tachyzoit
result
recoveri
function
fulllength
scfv
antibodi
previous
use
isol
function
antibodi
botulinum
toxin
chahboun
et
al
recoveri
sever
nonspecif
scfv
antibodi
initi
screen
highlight
propens
fals
posit
select
along
true
target
binder
vodnik
et
al
therefor
carri
extens
bioinformat
analysi
put
gondiibind
scfv
sequenc
rule
fals
posit
immatur
antibodi
similar
germlin
antibodi
sequenc
vodnik
et
al
antibodi
sequenc
screen
sarotup
mimodb
databas
exclud
clone
tup
motif
ident
peptid
select
differ
target
would
indic
nonspecif
bind
found
scfv
affinitymatur
counterpart
lack
known
tup
motif
contain
ident
peptid
hit
mimodb
databas
make
like
candid
show
specif
highaffin
bind
gondii
low
cross
reactiv
molecular
structur
reveal
chang
amino
acid
residu
cdr
framework
region
respect
close
agreement
observ
somat
hypermut
trend
humor
respons
wherebi
averag
mutat
probabl
antigencombin
site
core
residu
respect
clark
et
al
somat
mutat
variabl
region
provid
increas
ligand
divers
also
establish
hallmark
vivo
affin
matur
result
antigen
exposur
tonegawa
french
laskov
scharff
signific
sequenc
structur
chang
found
within
scfv
indic
antigendriven
select
process
antibodi
matur
germlin
precursor
analysi
variabl
domain
sequenc
reveal
closest
murin
germlin
sequenc
match
scfv
v
h
gene
famili
j
segment
togeth
germlin
element
correl
protect
immun
parasit
infect
mccoy
et
al
exampl
found
murin
inhibitori
antibodi
gondii
chen
et
al
found
murin
inhibitori
antibodi
plasmodium
spp
igonet
et
al
closest
murin
germlin
sequenc
match
scfv
v
l
gene
famili
j
segment
unlik
predomin
gene
hc
repertoir
antibodi
involv
parasit
infect
weak
bia
toward
famili
lc
igonet
et
al
lazar
et
al
protect
antibodi
p
falciparum
antigen
compris
v
h
v
l
repertoir
scfv
lazar
et
al
v
h
region
scfv
show
ident
germlin
sequenc
amino
acid
level
typic
affinitymatur
antigendriven
immun
respons
agre
sever
previou
phageantibodi
display
studi
scfv
igg
show
compar
level
somat
hypermut
exampl
sever
cancertarget
antibodi
describ
ident
germlin
sequenc
v
h
region
hansen
nielsen
ditzel
ho
et
al
virustarget
antibodi
describ
ident
david
et
al
ray
et
al
similar
trend
also
observ
v
l
region
antibodi
rgyw
hotspot
motif
dna
sequenc
frequent
mutat
vivo
affin
matur
neuberg
milstein
et
al
vquest
analysi
scfv
lefranc
reveal
total
five
rgyw
hotspot
within
variabl
region
locat
within
cdr
fig
hotspot
found
either
germlin
sequenc
close
nongermlin
sequenc
focus
germlin
sequenc
previou
studi
shown
suitabl
affin
matur
vitro
ho
et
al
chose
germlin
rgyw
hotspot
sequenc
within
v
l
preliminari
round
affin
matur
pair
degener
primer
span
target
rgyw
sequenc
design
introduc
random
pair
amino
acid
substitut
stop
codon
thu
avoid
gener
truncat
nonfunct
antibodi
bind
specif
scfv
antibodi
convert
igg
demonstr
elisa
reveal
significantli
higher
bind
affin
target
parasit
compar
neg
control
antigen
howev
character
igg
show
affinitymatur
igg
confer
greater
bind
affin
parasit
antigen
compar
parent
igg
avoid
issu
incorpor
elisa
test
mutat
scfv
help
inform
select
higher
affin
antibodi
candid
igg
convers
consid
similar
work
found
immunoblot
data
complet
commensur
strong
elisa
signal
five
recombin
igg
antibodi
test
two
parent
show
clearli
posit
immunoblot
signal
reveal
one
two
substitut
cdr
result
conspicu
differ
antibodi
bind
characterist
expect
mutagenesi
often
occur
hotspot
residu
serv
ligand
bind
site
immunoblot
analysi
use
fraction
nonreduc
parasit
lysat
show
two
posit
antibodi
bound
antigen
kda
suggest
epitop
recogn
parent
antibodi
deriv
reduc
nonreduc
immunoblot
fig
show
differ
band
pattern
nonreduc
blot
show
fewer
band
compar
reduc
blotsind
parasit
multimer
protein
disulfid
bond
intact
also
shown
anoth
studi
immunoblot
analysi
gondii
parasit
lysat
reduc
condit
would
tend
result
multipl
nonspecif
band
promin
band
proteinofinterest
besteiro
et
al
therefor
import
run
immunoblot
analysi
reduc
nonreduc
condit
gain
better
clariti
specif
antibodi
interestingli
affinitymatur
igg
bound
lower
effici
gondii
lysat
parent
antibodi
despit
show
specif
overal
result
show
pair
amino
acid
substitut
within
v
l
signific
impact
elisa
immunoblot
perform
chang
better
toler
ifa
experi
sequenc
bia
affinitymatur
antibodi
librari
effect
unlik
case
evalu
sequenc
divers
show
neareven
sequenc
distribut
target
loci
tabl
howev
possibl
affin
threshold
factor
affect
format
antibodyantigen
complex
document
sever
cancertarget
antibodi
nielsen
et
al
support
lack
correl
antibodi
affin
specif
function
nap
et
al
instanc
loweraffin
antibodi
shown
better
target
retent
properti
nielsen
et
al
rudnick
et
al
yu
et
al
bienli
et
al
find
confirm
function
antibodi
influenc
mani
differ
factor
current
investig
context
interact
identifi
parasit
epitop
involv
also
found
treat
tachyzoit
plantderiv
igg
inhibit
invas
host
cell
murin
polyclon
antibodi
gondii
surfac
antigen
previous
shown
inhibit
invas
respect
mineo
et
al
hehl
et
al
wherea
murin
monoclon
igg
rais
p
falciparum
erythrocyteinvas
antigen
achiev
inhibit
invas
triglia
et
al
monoclon
igg
studi
therefor
achiev
potent
inhibit
invas
compar
level
afford
polyclon
antisera
remark
experi
show
plantderiv
chimer
igg
also
inhibit
plaqu
format
gondii
hff
monolay
even
low
antibodi
dose
mgml
individu
attach
data
set
show
substanti
variabl
experi
igg
variant
except
demonstr
posit
block
activ
therefor
conclud
defect
parasit
attach
host
cell
may
main
inhibitori
mechan
play
substanti
contributori
role
base
encourag
find
current
investig
vivo
efficaci
antibodi
toxoplasmosi
infect
taken
togeth
result
demonstr
plantderiv
monoclon
antibodi
substanti
inhibit
vitro
activ
gondii
result
confirm
vivo
antibodi
could
develop
therapeut
option
immunocompromis
patient
suffer
toxoplasmosi
antibodybas
pharmaceut
one
fastestgrow
market
segment
biopharmaceut
industri
deploy
antibodi
infecti
diseas
restrict
high
product
cost
plant
address
issu
reduc
cost
antibodi
product
compar
fermenterbas
manufactur
daniel
streatfield
wycoff
beasley
well
offer
advantag
term
safeti
scalabl
stoger
et
al
chose
n
benthamiana
product
platform
antibodi
tobacco
famili
wellestablish
host
recombin
protein
express
recogn
regulatori
bodi
govern
product
biopharmaceut
schillberg
fischer
eman
stoger
et
al
tobacco
plant
produc
high
antibodi
yield
includ
tumorspecif
fulllength
human
igg
mgkg
fresh
biomass
giritch
et
al
frenzel
hust
schirrmann
mgkg
scfv
rosenberg
et
al
yield
mgkg
fresh
biomass
satisfactori
preliminari
proofofconcept
studi
optim
could
improv
coexpress
proteas
inhibitor
viral
protein
prevent
gene
silenc
summari
shown
gener
specif
antibodi
fragment
parasit
pathogen
achiev
pan
phage
display
librari
parasit
cell
ad
bioinformat
vet
access
approach
could
potenti
broad
implic
select
biologicallyrelev
protein
receptor
enzym
hapten
vaccin
epitop
also
demonstr
chimer
igg
deriv
scfv
antibodi
fragment
express
purifi
n
benthamiana
plant
retain
function
specif
gondii
make
suitabl
candid
treatment
vulner
patient
group
suffer
toxoplasmosi
work
support
highimpact
research
ministri
educ
grant
univers
malaya
research
grant
funder
role
studi
design
data
collect
analysi
decis
publish
prepar
manuscript
